Search

everythinglearnresearchcommunity

for

Search:↓

Selumetinib effectively reduces tumor size in many children with neurofibromatosis type 1, but can cause skin and hair issues.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

Copper deficiency is linked to post-COVID-19 hair loss in women.

RU 58841 may treat acne, hair loss, and excessive hair growth.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Low vitamin D levels are linked to symptoms like muscle cramps, fatigue, and hair loss.

Testosterone can slow down hair growth when combined with certain cells from bald scalps, and this effect can be blocked by an androgen receptor blocker.

Lower zinc levels may predict less effective hair loss treatment.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.

Sebaceous glands in the skin play a key role in absorbing the antiandrogen drug RU 58841, especially when it's encapsulated in liposomes.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Fetuin-A helps wounds heal without scars by promoting cell movement.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Metabolic syndrome can cause serious health issues and should be considered when treating women with severe acne.

Recognizing new allergens can help reduce contact dermatitis cases.

Estrogens and SERMs can help with skin aging, but their safety and effectiveness need more research.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.